跳至主要内容
临床试验/NCT07636161
NCT07636161尚未招募4 期

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon): A Pilot Randomized Trial of Eroxon® Gel as an Adjunct to Tadalafil in Young Men With Diabetes-Associated Erectile Dysfunction

University of Miami1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
30
试验地点
1

研究概览

简要总结

The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male sex at birth
  • Age 18-40 years
  • Diagnosis of type 2 diabetes mellitus
  • Diagnosis of erectile dysfunction
  • Currently prescribed tadalafil
  • Have a sexual partner willing to complete a survey
  • Ability to provide informed consent

排除标准

  • Type 1 diabetes mellitus
  • Severe psychiatric illness that would impair participation
  • Use of nitrates or contraindications to sexual activity
  • Known allergy to Eroxon® gel components
  • Participation in another interventional sexual health study

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sonjia Kenya

Professor of Professional Practice

University of Miami

研究点 (1)

Loading locations...

相似试验